Yildirim, Timur M.
Fang, Hui
Schickhardt, Sonja K.
Wang, Qiang
Merz, Patrick R.
Auffarth, Gerd U.
Funding for this research was provided by:
Klaus Tschira Stiftung
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Article History
Received: 10 October 2019
Accepted: 13 April 2020
First Online: 6 May 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The David J. Apple International Laboratory for Ocular Pathology receives research grants from Alcon and Biotech. T. Yildirim reports non-financial support from Alcon, outside the submitted work. G. Auffarth reports grants, personal fees and non-financial support from Alcon, Johnson & Johnson Vision, Oculentis, Hoya, Kowa, Rayner, Sifi, Presbia, Oculus, Ursapharm, Glaukos and Carl Zeiss Meditec, grants and personal fees from Bausch+Lomb and Biotech, grants and non-financial support from Santen and Alimera, grants from Acufocus, Physiol, Anew and Contamac, outside the submitted work. H. Fang, S. Schickhardt, Q. Wang and P. Merz have nothing to disclose.